Literature DB >> 2962193

Expression of a synthetic bovine rhodopsin gene in monkey kidney cells.

D D Oprian1, R S Molday, R J Kaufman, H G Khorana.   

Abstract

We report here the high-level expression of a synthetic gene for bovine rhodopsin in transfected monkey kidney COS-1 cells. Rhodopsin is produced in these cells to a level of 0.3% of the cell protein, and it binds exogenously added 11-cis-retinal to generate the characteristic rhodopsin absorption spectrum. We describe a one-step immunoaffinity procedure for purification of the rhodopsin essentially to homogeneity. The COS-1 cell rhodopsin activates the GTPase activity of bovine transducin in a light-dependent manner with the same specific activity as that of purified bovine rhodopsin. Electron microscopy of immunogold-stained cells indicates that rhodopsin is located in the plasma membrane of the transfected cells and is oriented with the amino terminus on the extracellular side of the membrane. This orientation is analogous to that of rhodopsin in the disk membranes of photoreceptor cells in the bovine retina.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2962193      PMCID: PMC299653          DOI: 10.1073/pnas.84.24.8874

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Assay of proteins in the presence of interfering materials.

Authors:  A Bensadoun; D Weinstein
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

2.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Expression of chimeric genes in the early region of SV40.

Authors:  M Horowitz; C L Cepko; P A Sharp
Journal:  J Mol Appl Genet       Date:  1983

5.  Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin.

Authors:  J Nathans; D S Hogness
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

6.  Monoclonal antibodies to rhodopsin: characterization, cross-reactivity, and application as structural probes.

Authors:  R S Molday; D MacKenzie
Journal:  Biochemistry       Date:  1983-02-01       Impact factor: 3.162

7.  Localization of binding sites for carboxyl terminal specific anti-rhodopsin monoclonal antibodies using synthetic peptides.

Authors:  D MacKenzie; A Arendt; P Hargrave; J H McDowell; R S Molday
Journal:  Biochemistry       Date:  1984-12-18       Impact factor: 3.162

8.  An improved technique for obtaining enhanced infectivity with herpes simplex virus type 1 DNA.

Authors:  N D Stow; N M Wilkie
Journal:  J Gen Virol       Date:  1976-12       Impact factor: 3.891

9.  Flow of information in the light-triggered cyclic nucleotide cascade of vision.

Authors:  B K Fung; J B Hurley; L Stryer
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

10.  Peripherin. A rim-specific membrane protein of rod outer segment discs.

Authors:  R S Molday; D Hicks; L Molday
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-01       Impact factor: 4.799

View more
  157 in total

1.  Solution 19F nuclear Overhauser effects in structural studies of the cytoplasmic domain of mammalian rhodopsin.

Authors:  M C Loewen; J Klein-Seetharaman; E V Getmanova; P J Reeves; H Schwalbe; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Large-scale production and purification of functional recombinant bovine rhodopsin with the use of the baculovirus expression system.

Authors:  C H Klaassen; P H Bovee-Geurts; G L Decaluwé; W J DeGrip
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

3.  Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution.

Authors:  X Yang; L Florin; M Farzan; P Kolchinsky; P D Kwong; J Sodroski; R Wyatt
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Structural origins of constitutive activation in rhodopsin: Role of the K296/E113 salt bridge.

Authors:  Jong-Myoung Kim; Christian Altenbach; Masahiro Kono; Daniel D Oprian; Wayne L Hubbell; H Gobind Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

5.  Molecular mechanisms of disease for mutations at Gly-90 in rhodopsin.

Authors:  Darwin Toledo; Eva Ramon; Mònica Aguilà; Arnau Cordomí; Juan J Pérez; Hugo F Mendes; Michael E Cheetham; Pere Garriga
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

6.  Structure and function in rhodopsin: kinetic studies of retinal binding to purified opsin mutants in defined phospholipid-detergent mixtures serve as probes of the retinal binding pocket.

Authors:  P J Reeves; J Hwa; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  Convergent evolution of the red- and green-like visual pigment genes in fish, Astyanax fasciatus, and human.

Authors:  R Yokoyama; S Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  Assembly of an activated rhodopsin-transducin complex in nanoscale lipid bilayers.

Authors:  Aaron M D'Antona; Guifu Xie; Stephen G Sligar; Daniel D Oprian
Journal:  Biochemistry       Date:  2013-12-20       Impact factor: 3.162

9.  Functional characterization of rhodopsin monomers and dimers in detergents.

Authors:  Beata Jastrzebska; Tadao Maeda; Li Zhu; Dimitrios Fotiadis; Slawomir Filipek; Andreas Engel; Ronald E Stenkamp; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2004-10-15       Impact factor: 5.157

10.  Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration.

Authors:  N J Colley; J A Cassill; E K Baker; C S Zuker
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.